Similarly, HIF levels were reduced in treated tumors but remained elevated in most tumor cells of EC-vGPCR (10%) + EC- vCYC/vFLIP/RR-mTOR (90%) allografts even after treatment with Rapamycin (Fig. 5). Here, MTOR is linked to neoplasm.